المصدر: Zacks Investment Research
وكالة أنباء
الأسهم
أهمية متوسطة

Can Acadia (ACAD) Run Higher on Rising Earnings Estimates?
Acadia Pharmaceuticals (ACAD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
الرموز ذات الصلة
1
A
ACAD
ACAD
المصدر: Zacks Investment Research
زيارة المصدر